Discrimination of vascular proliferation in eyelid surgery using multimodal hyperspectral imaging technology
Computer Methods and Programs in Biomedicine · 2026
DOI: 10.1016/j.cmpb.2026.109328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computer Methods and Programs in Biomedicine, 2026. Verfasst von Chongxuan Tian und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Control Science and Engineering, Shandong University, Jinan, China. Hauptthemen laut MEDLINE: Hyperspectral Imaging, Eyelids, Multimodal Imaging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Key Research and Development Program of China Stem Cell and Translational Research, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
BACKGROUND AND OBJECTIVE: Vascular proliferation is a common skin reaction following eyelid surgery, and early diagnosis is crucial for improving treatment outcomes. This study proposes a multimodal framework for the diagnosis of vascular proliferation in eyelid tissues, in which hyperspectral images provide spectral-spatial information related to microvascular changes, while corresponding pathological slice images provide complementary microscopic morphological information. These two modalities were jointly analyzed using the HyperT-net deep learning model. METHODS: Hyperspectral data ranging from 400 to 1000 nm and corresponding pathological slice images were collected for model development and evaluation. A combination of one-dimensional convolutional networks and Transformer architecture was employed to build the HyperT-net model for data analysis. RESULTS: The proposed approach effectively captures subtle changes in skin microvasculature, providing a non-invasive and precise tool for skin condition assessment. Compared to existing methods, our approach demonstrates superior accuracy and sensitivity, particularly in the early detection of vascular proliferation. Additionally, ablation experiments reveal that each component of the model plays a critical role in enhancing its performance. CONCLUSIONS: This research introduces a novel technological pathway for diagnosing vascular proliferation in the field of medical aesthetics and lays the foundation for the future promotion of related applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Control Science and Engineering, Shandong University, Jinan, China.
- Plastic Surgery Department, The First Affiliated Hospital of Shandong First Medical University, Jinan, China.
- Plastic Surgery Department, The First Affiliated Hospital of Shandong First Medical University, Jinan, China. Electronic address: cloudseasky@126.com.
- School of Control Science and Engineering, Shandong University, Jinan, China. Electronic address: cindy@sdu.edu.cn.
Förderung
- National Key Research and Development Program of China Stem Cell and Translational Research
- National Natural Science Foundation of China
- National Key Research and Development Program of China
- Shandong Province Natural Science Foundation
- Key Technology Research and Development Program of Shandong
Zitieren
APA
Tian, C., Jiang, Z., Gu, X., Lv, Q., Liu, X., Deng, J., An, G., & Li, W. (2026). Discrimination of vascular proliferation in eyelid surgery using multimodal hyperspectral imaging technology. Computer Methods and Programs in Biomedicine. https://doi.org/10.1016/j.cmpb.2026.109328
Vancouver
Tian C, Jiang Z, Gu X, Lv Q, Liu X, Deng J, et al. Discrimination of vascular proliferation in eyelid surgery using multimodal hyperspectral imaging technology. Computer Methods and Programs in Biomedicine. 2026. doi:10.1016/j.cmpb.2026.109328
BibTeX
@article{Tian2026,
author = {Tian, Chongxuan and Jiang, Zhengshuai and Gu, Xiaming and Lv, Qize and Liu, Xiaodong and Deng, Jinlin and An, Gang and Li, Wei},
title = {Discrimination of vascular proliferation in eyelid surgery using multimodal hyperspectral imaging technology},
journal = {Computer Methods and Programs in Biomedicine},
year = {2026},
doi = {10.1016/j.cmpb.2026.109328}
}
EUVIMED